Kura (KURA) Chief Legal Officer Teresa Brophy Bair Sells 8,442 Shares

What Happened Teresa Brophy Bair, Chief Legal Officer of Kura Oncology (KURA), sold 8,442 shares in an open-market/ordinary sale on 2026-09-28 at $10.50 per share, generating proceeds of $88,618. The sale was a sell-to-cover transaction to satisfy tax withholding tied to the vesting of performance-based restricted stock units (PSUs), not a discretionary market-timed sale.

Key Details

• Transaction date and price: 2026-09-28, 8,442 shares at $10.50 each.
• Proceeds: $88,618 (gross).
• Reason (footnote): Sell-to-cover for taxes on the vesting of 1/6th of PSUs granted May 31, 2023; the one-year anniversary of a specified development milestone was met on 2026-09-27, triggering the vesting.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Reported on 2026-09-29 (filed one day after the transaction), which is within the usual Form 4 reporting window.

Context PSUs are performance-based awards that convert to shares only if specified milestones (and any time-based requirements) are met. A sell-to-cover is a routine transaction where a portion of vested shares are sold solely to cover tax withholding obligations and generally does not by itself indicate the insider's view on the company.